COMMUNIQUÉS West-GlobeNewswire

Ipsen - Août 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/09/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
VALNEVA - Declaration of shares and voting rights: August 31, 2024
04/09/2024
VALNEVA Declaration of shares and voting rights August 31, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
VALNEVA - Déclaration d’actions et de droits de vote : 31 août 2024
04/09/2024
VALNEVA Déclaration d’actions et de droits de vote 31 août 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]
Americans Are Wandering in Wonderland, Writes President of the Association of American Physicians and Surgeons (AAPS)
04/09/2024
TUCSON, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Almost four years into the COVID saga, Americans still seem to be in a dystopian world reminiscent of Lewis Carroll’s 1865 Alice in Wonderland , writes Jane Lindell [...]
Politicized Medicine Hindered Use of Ivermectin for COVID, according to the Journal of American Physicians and Surgeons
04/09/2024
TUCSON, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The heavily politicized response to COVID included a war on the use of ivermectin, an antiparasitic drug, despite the previously favorable response to the repurposing of [...]
Greg Thompson Joins NewLeaf Board of Directors
04/09/2024
Biological and agriculture industry veteran to add unique expertise as advisor to the science-led start-up ST. LOUIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- NewLeaf Symbiotics, the global leader in Pink Pigmented [...]
Wellinks Recognized as Quarterfinalist for the Digital Health Hub Foundation: Digital Health Awards
04/09/2024
NEW HAVEN, Conn., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Wellinks, is thrilled to announce its selection as a quarterfinalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. Wellinks was [...]
Artificial Intelligence Systems (AI) Are Programmed to Lie, according to Journal of American Physicians and Surgeons
04/09/2024
TUCSON, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- After thousands of conversations with artificial intelligence (AI) systems, software developer Jonathan Cohler concludes that they lie, they know they are lying, and [...]
Methods to Undo Damage from Bad-Faith Peer Review Discussed in Journal of American Physicians and Surgeons
04/09/2024
TUCSON, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- A bad-faith or sham peer review can ruin a physician’s entire career, but there are some methods that might help undo the damage, writes Lawrence Huntoon , M.D., Ph.D., [...]
ARCPOINT PROVIDES CORPORATE UPDATE ON BENEFITS OF CRESSO TRANSACTION
03/09/2024
Greenville, South Carolina, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to provide the following corporate update and will host a conference call at 4:45pm [...]
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
03/09/2024
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed
03/09/2024
ANKARA, Turkey, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) (“Company”) and Atlantic Logistics announce there will be no merger with KARINCA Logistics. The previous announcement on August [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2024
SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics [...]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024
03/09/2024
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”), a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, [...]
Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)
03/09/2024
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve [...]
Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
03/09/2024
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving [...]
BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida
03/09/2024
LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/09/2024
CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
Cellectis présente des preuves précliniques de l’efficacité des cellules CAR T MUC1 contre le cancer du sein triple négatif tout en préservant la sécurité
03/09/2024
NEW YORK, 03 sept. 2024 (GLOBE NEWSWIRE) -- Cellectis (la "Société") (Euronext Growth : ALCLS - NASDAQ : CLLS), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome TALEN [...]

Pages